Skip to Main Content

Paper Details

Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using <sup>89</sup>Zr-DFO-MSTP2109A Anti-STEAP1 Antibody.
J Nucl Med
32
2019
89Zr, 89Zr-, 89Zr-DFO-MSTP2109A, ADC, Anti-STEAP1 Antibody, DFO-, DFO-MSTP2109A, MSTP2109A, Metastatic Castration-Resistant Prostate Cancer, Patients, STEAP1, Six-transmembrane epithelial antigen of prostate-1, mCRPC, patients, prostate cancer, prostate-specific antigen, soft-tissue disease, tumor
Author NameAffiliation
Neeta Pandit-TaskarMemorial Sloan Kettering Cancer Center
Neeta Pandit-TaskarWeill Cornell Medical Center
Neeta Pandit-TaskarCenter for Targeted Radioimmunotherapy and Diagnosis, Ludwig Center for Cancer Immunotherapy
John L HummMemorial Sloan Kettering Cancer Center
Howard I ScherMemorial Sloan Kettering Cancer Center
Howard I Scher
Mithat GonenMemorial Sloan Kettering Cancer Center
Michael J MorrisMemorial Sloan Kettering Cancer Center
Michael J Morris
  • 1 - 9

Datasets

Release 1.2